Using recombinant monoclonal IgG1, the loss of OPCs is practically complete in NMOSD, unlike in multiple sclerosis, in which it decreases to 50% [45]; therefore, with the presence of AQP4–IgG, remyelination may be difficult [46]. This evidence concerns the gene AQP4 and multiple sclerosis.